Literature DB >> 19283385

Thoracic and abdominal MRA with gadofosveset: influence of injection rate on vessel signal and image quality.

Johanna C Nissen1, Ulrike I Attenberger, Christian Fink, Olaf Dietrich, Martin Rohrer, Stefan O Schoenberg, Henrik J Michaely.   

Abstract

The purpose of this study was to investigate the influence of different injection rates on the maximum signal intensity and the arterio-venous transit time of dynamic gadofosveset-enhanced first pass MR angiography (MRA). Twenty-one healthy male volunteers were examined with a time-resolved echo-shared MRA at 1.5 T. The volunteers were assigned into three groups using injection rates of either 1, 2 or 4 ml/s. The maximal signal enhancement and peak signal-to-noise ratio in the pulmonary trunk, the aortic arch, the abdominal aorta as well as both kidneys and lung parenchyma were analyzed. The arterio-venous transit time was determined. The time between maximal enhancement of the pulmonary trunk and the aortic arch was higher with the slow injection rate of 1 ml/s, while there were no differences in the time between maximal enhancement of the aortic arch and the abdominal aorta above or below the origin of the renal veins with all three injection rates. With the slow injection protocol of 1 ml/s a longer purely arterial phase of 10.5 s was achieved compared to 7.7 s with higher injection rates (p = 0.045). The time between maximal aortic signal intensity and maximal renal enhancement was equal for all injection protocols.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19283385     DOI: 10.1007/s00330-009-1381-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  14 in total

1.  Generalized autocalibrating partially parallel acquisitions (GRAPPA).

Authors:  Mark A Griswold; Peter M Jakob; Robin M Heidemann; Mathias Nittka; Vladimir Jellus; Jianmin Wang; Berthold Kiefer; Axel Haase
Journal:  Magn Reson Med       Date:  2002-06       Impact factor: 4.668

2.  Contrast-enhanced three-dimensional pulmonary perfusion magnetic resonance imaging: intraindividual comparison of 1.0 M gadobutrol and 0.5 M Gd-DTPA at three dose levels.

Authors:  Christian Fink; Michael Puderbach; Sebastian Ley; Christian Plathow; Michael Bock; Ivan Zuna; Hans-Ulrich Kauczor
Journal:  Invest Radiol       Date:  2004-03       Impact factor: 6.016

Review 3.  Initial imaging recommendations for Vasovist angiography.

Authors:  Mike Hartmann; Andrea J Wiethoff; Hans-Rainer Hentrich; Martin Rohrer
Journal:  Eur Radiol       Date:  2006-02       Impact factor: 5.315

4.  Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths.

Authors:  Martin Rohrer; Hans Bauer; Jan Mintorovitch; Martin Requardt; Hanns-Joachim Weinmann
Journal:  Invest Radiol       Date:  2005-11       Impact factor: 6.016

5.  Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters.

Authors:  Olaf Dietrich; José G Raya; Scott B Reeder; Maximilian F Reiser; Stefan O Schoenberg
Journal:  J Magn Reson Imaging       Date:  2007-08       Impact factor: 4.813

6.  Time-resolved contrast-enhanced 3D MR angiography.

Authors:  F R Korosec; R Frayne; T M Grist; C A Mistretta
Journal:  Magn Reson Med       Date:  1996-09       Impact factor: 4.668

7.  The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.

Authors:  Peter Caravan; Normand J Cloutier; Matthew T Greenfield; Sarah A McDermid; Stephen U Dunham; Jeff W M Bulte; John C Amedio; Richard J Looby; Ronald M Supkowski; William DeW Horrocks; Thomas J McMurry; Randall B Lauffer
Journal:  J Am Chem Soc       Date:  2002-03-27       Impact factor: 15.419

8.  MS-325: albumin-targeted contrast agent for MR angiography.

Authors:  R B Lauffer; D J Parmelee; S U Dunham; H S Ouellet; R P Dolan; S Witte; T J McMurry; R C Walovitch
Journal:  Radiology       Date:  1998-05       Impact factor: 11.105

9.  Species dependence on plasma protein binding and relaxivity of the gadolinium-based MRI contrast agent MS-325.

Authors:  Harriet B Eldredge; Marga Spiller; Jaclyn M Chasse; Matthew T Greenwood; Peter Caravan
Journal:  Invest Radiol       Date:  2006-03       Impact factor: 6.016

10.  First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.

Authors:  Christian Klessen; Patrick A Hein; Alexander Huppertz; Matthias Voth; Moritz Wagner; Thomas Elgeti; Hannes Kroll; Bernd Hamm; Matthias Taupitz; Patrick Asbach
Journal:  Invest Radiol       Date:  2007-09       Impact factor: 6.016

View more
  4 in total

1.  Improved quality and diagnostic confidence achieved by use of dose-reduced gadolinium blood-pool agents for time-resolved intracranial MR angiography.

Authors:  S Dehkharghani; J Kang; A M Saindane
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-22       Impact factor: 3.825

2.  Magnetic resonance venography and liver transplant complications.

Authors:  Evgeny Strovski; Dave Liu; Charles Scudamore; Stephen Ho; Eric Yoshida; Darren Klass
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

3.  Combined renal MRA and perfusion with a single dose of contrast.

Authors:  Parmede Vakil; James C Carr; Timothy J Carroll
Journal:  Magn Reson Imaging       Date:  2012-04-20       Impact factor: 2.546

4.  Contrast-enhanced time-resolved 4D MRA of congenital heart and vessel anomalies: image quality and diagnostic value compared with 3D MRA.

Authors:  Florian M Vogt; Jens M Theysohn; Dariusz Michna; Peter Hunold; Ulrich Neudorf; Sonja Kinner; Jörg Barkhausen; Harald H Quick
Journal:  Eur Radiol       Date:  2013-05-04       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.